Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum
Authors:
- Jean-François HeilierJHJean-François Heilier
- Olivier DonnezODOlivier Donnez
- Valérie Van KerckhoveVKValérie Van Kerckhove
- Dominique LisonDLDominique Lison
- Jacques DonnezJDJacques Donnez
- 1 May 2006
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 85 (5) , 1516-1518
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- New medical treatments for endometriosisBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- High endometrial aromatase P450 mRNA expression is associated with poor IVF outcomeHuman Reproduction, 2004
- Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomasFertility and Sterility, 2003
- Endometriosis: the pathophysiology as an estrogen-dependent diseaseThe Journal of Steroid Biochemistry and Molecular Biology, 2002
- Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entitiesFertility and Sterility, 1997
- Peritoneal endometriosis and “endometriotic” nodules of the rectovaginal septum are two different entitiesFertility and Sterility, 1996